Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours Β· Estimated delivery Aug 8 - Aug 13
Use of a proliferation-based mRNA signature to predict outcome in early-stage non-small cell lung adenocarcinoma
,
Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models
Food and Drug Administration (FDA), with the drug quickly being in demand following media coverage of its potential
[34] observed an increase in insulin sensitivity of up to 30% in hyperglycaemic clamp studies in moderately obese elderly patients with type 2 diabetes receiving acarbose 50 to 100mg three times daily for 12 months
US$ 22.97
US$ 20.30
US$ 27.32
